U.S. Physical Therapy, Inc.
USPHNYSEHealthcare● Active
$61.30
$-2.15(-3.39%)
Market Cap$932912440
P/E Ratio—
52W High$93.5
52W Low$58.19
U.S. Physical Therapy, Inc. (USPH) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
USPH · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
$0.46
Est. $0.55 · -16.4%
Revenue
$0.20B
Est. $0.20B · -1.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
USPH reports quarterly as a NYSE-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | $0.85 | — | — | — | $0.21B | — |
| ▼ Q2 FY2026 | May 6, 2026 | $0.55 | $0.46 | -16.4% | $0.20B | $0.20B | -1.3% |
| — Q1 FY2026 | Feb 25, 2026 | $0.67 | $0.67 | +0.0% | $0.20B | $0.20B | +1.4% |
| ▼ Q4 FY2025 | Nov 5, 2025 | $0.67 | $0.66 | -1.5% | $0.16B | $0.20B | -18.0% |
| ▲ Q3 FY2025 | Aug 6, 2025 | $0.71 | $0.81 | +14.1% | $0.16B | $0.19B | -13.5% |
| ▲ Q2 FY2025 | May 7, 2025 | $0.46 | $0.48 | +4.3% | $0.15B | $0.19B | -18.9% |
| ▼ Q1 FY2025 | Feb 26, 2025 | $0.69 | $0.65 | -5.8% | $0.18B | $0.17B | +4.2% |
| ▲ Q4 FY2024 | Nov 5, 2024 | $0.68 | $0.69 | +1.5% | $0.17B | $0.17B | -2.2% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
$0.85
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Miss
EPS Actual
$0.46
EPS Est.
$0.55
EPS Surpr.
-16.4%
Revenue
$0.20B
Q1 FY2026
Feb 25, 2026
EPS Actual
$0.67
EPS Est.
$0.67
EPS Surpr.
+0.0%
Revenue
$0.20B
Q4 FY2025
Nov 5, 2025Miss
EPS Actual
$0.66
EPS Est.
$0.67
EPS Surpr.
-1.5%
Revenue
$0.16B
Q3 FY2025
Aug 6, 2025Beat
EPS Actual
$0.81
EPS Est.
$0.71
EPS Surpr.
+14.1%
Revenue
$0.16B
Q2 FY2025
May 7, 2025Beat
EPS Actual
$0.48
EPS Est.
$0.46
EPS Surpr.
+4.3%
Revenue
$0.15B
Q1 FY2025
Feb 26, 2025Miss
EPS Actual
$0.65
EPS Est.
$0.69
EPS Surpr.
-5.8%
Revenue
$0.18B
Q4 FY2024
Nov 5, 2024Beat
EPS Actual
$0.69
EPS Est.
$0.68
EPS Surpr.
+1.5%
Revenue
$0.17B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.91 | $0.92 | $0.94 | 1 |
| Q3 FY2027 | $0.86 | $0.88 | $0.90 | 1 |
| Q2 FY2027 | $0.95 | $0.96 | $0.99 | 1 |
| Q1 FY2027 | $0.55 | $0.56 | $0.57 | 1 |
| Q4 FY2026 | $0.85 | $0.86 | $0.88 | 1 |
| Q3 FY2026 | $0.69 | $0.77 | $0.85 | 5 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.2B | $0.2B | $0.2B | 2 |
| Q3 FY2027 | $0.2B | $0.2B | $0.2B | 2 |
| Q2 FY2027 | $0.2B | $0.2B | $0.2B | 2 |
| Q1 FY2027 | $0.2B | $0.2B | $0.2B | 2 |
| Q4 FY2026 | $0.2B | $0.2B | $0.2B | 2 |
| Q3 FY2026 | $0.2B | $0.2B | $0.2B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 6, 2026 | -16.4% | $71.74 | $73.65 | +2.66% |
| ▲ Q1 FY2026 | Feb 25, 2026 | +0.0% | $82.88 | $81.68 | -1.45% |
| ▼ Q4 FY2025 | Nov 5, 2025 | -1.5% | $87.04 | $88.05 | +1.16% |
| ▲ Q3 FY2025 | Aug 6, 2025 | +14.1% | $72.02 | $72.69 | +0.93% |
| ▲ Q2 FY2025 | May 7, 2025 | +4.3% | $71.57 | $70.96 | -0.85% |
| ▼ Q1 FY2025 | Feb 26, 2025 | -5.8% | $88.08 | $87.72 | -0.41% |
| ▲ Q4 FY2024 | Nov 5, 2024 | +1.5% | $82.80 | $82.53 | -0.33% |
| ▼ Q3 FY2024 | Aug 13, 2024 | -9.9% | $87.60 | $90.00 | +2.74% |
Q2 FY2026+2.66%
Report Date
May 6, 2026
EPS Beat/Miss
-16.4%
Price Before
$71.74
Price After
$73.65
Q1 FY2026-1.45%
Report Date
Feb 25, 2026
EPS Beat/Miss
+0.0%
Price Before
$82.88
Price After
$81.68
Q4 FY2025+1.16%
Report Date
Nov 5, 2025
EPS Beat/Miss
-1.5%
Price Before
$87.04
Price After
$88.05
Q3 FY2025+0.93%
Report Date
Aug 6, 2025
EPS Beat/Miss
+14.1%
Price Before
$72.02
Price After
$72.69
Q2 FY2025-0.85%
Report Date
May 7, 2025
EPS Beat/Miss
+4.3%
Price Before
$71.57
Price After
$70.96
Q1 FY2025-0.41%
Report Date
Feb 26, 2025
EPS Beat/Miss
-5.8%
Price Before
$88.08
Price After
$87.72
Q4 FY2024-0.33%
Report Date
Nov 5, 2024
EPS Beat/Miss
+1.5%
Price Before
$82.80
Price After
$82.53
Q3 FY2024+2.74%
Report Date
Aug 13, 2024
EPS Beat/Miss
-9.9%
Price Before
$87.60
Price After
$90.00
Avg Beat Reaction-0.42%
Avg Miss Reaction+1.54%
Beat Rate4 / 8 quarters
Largest Move+2.74% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: USPH ends December
U.S. Physical Therapy, Inc. (USPH) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $0.46 — missing the analyst consensus of $0.55 by -16.4%. The next USPH earnings date is expected around September 1, 2026.
Each quarter, investors track USPH earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. USPH revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
USPH's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
USPH earnings · 5 questionsU.S. Physical Therapy, Inc.'s next earnings report is expected around September 1, 2026. USPH typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; USPH historically reports after market close (AMC).
USPH earnings datewhen is USPH earningsUSPH next earnings datewhen does USPH report earningsUSPH earnings calendar
▸ Source: FMP · U.S. Physical Therapy, Inc. SEC filings · US GAAP · U.S. Physical Therapy, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026